Companies / Kalaris Therapeutics, Inc. / Activity
Activity — Kalaris Therapeutics, Inc.
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common Stock | $343.5K | +60K | 59,534 0.25% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common Stock | $67.3K | +17K | 16,527 0.07% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | New | Common Stock | $51.2K | +6K | 6,065 0.03% of shares | low |
| Q2 2026 as of | Sigma Planning Corp 13F manager | New | Common Stock | $41.4K | +10K | 10,167 0.04% of shares | low |
| Q1 2026 as of | Federated Hermes Inc 13F manager | New | Common Stock | $196 | +34 | 34 <0.01% of shares | low |
| Q1 2025 as of | Barclays PLC 13F manager | New | Common Stock | $8 | +1 | 1 <0.01% of shares | low |